Kotanidou, S.; Dampali, R.; Devaja, O.; Attard-Montalto, S.; Godfrey, M.; Papadopoulos, A.J.; Daniilidis, A.; Nikolettos, N.; Nikolettos, K.
Glucagon-like Peptide-1 Receptor Agonists and Endometrial Cancer: Potential Future in Fertility-Sparing Treatment. Reprod. Med. 2026, 7, 34.
https://doi.org/10.3390/reprodmed7030034
AMA Style
Kotanidou S, Dampali R, Devaja O, Attard-Montalto S, Godfrey M, Papadopoulos AJ, Daniilidis A, Nikolettos N, Nikolettos K.
Glucagon-like Peptide-1 Receptor Agonists and Endometrial Cancer: Potential Future in Fertility-Sparing Treatment. Reproductive Medicine. 2026; 7(3):34.
https://doi.org/10.3390/reprodmed7030034
Chicago/Turabian Style
Kotanidou, Sonia, Roxani Dampali, Omer Devaja, Stephen Attard-Montalto, Michelle Godfrey, Andreas John Papadopoulos, Angelos Daniilidis, Nikolaos Nikolettos, and Konstantinos Nikolettos.
2026. "Glucagon-like Peptide-1 Receptor Agonists and Endometrial Cancer: Potential Future in Fertility-Sparing Treatment" Reproductive Medicine 7, no. 3: 34.
https://doi.org/10.3390/reprodmed7030034
APA Style
Kotanidou, S., Dampali, R., Devaja, O., Attard-Montalto, S., Godfrey, M., Papadopoulos, A. J., Daniilidis, A., Nikolettos, N., & Nikolettos, K.
(2026). Glucagon-like Peptide-1 Receptor Agonists and Endometrial Cancer: Potential Future in Fertility-Sparing Treatment. Reproductive Medicine, 7(3), 34.
https://doi.org/10.3390/reprodmed7030034
